Lipid C2

Overview

Lipid C2 is an ionizable cationic lipid that has been used in the formation of lipid nanoparticles ( LNP ) for mRNA delivery in vivo. LNPs containing Lipid C2 and encapsulating an mRNA reporter selectively accumulate in the liver and spleen but not the heart, lungs, or kidneys in mice. LNP containing Lipid C2 and encapsulating mRNA encoding the Epstein-Barr virus ( EBV ) protein latent membrane protein 2 (LMP-2), in combination with an anti-programmed cell death protein 1 ( PD-1 ) antibody, decrease tumor volume and reverse T cell exhaustion, as well as increase the percentage of CD3 + CD8 + central and CD3 + CD8 + effector memory T cells and decrease the percentage of CD3 + T cells expressing Pd-1 , in the spleen in a CT26 murine EBV-infected colon cancer model.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Infection | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Infection | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Immunotherapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Liposome

Product Information

• Catalog No.: HY-169480
• CAS No.: 3003022-09-8
• Molecular Formula: C70H142N6O6
• Molecular Weight: 1163.91
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source